Login / Signup

Risankizumab vs. adalimumab for moderate-to-severe plaque psoriasis: a critical appraisal.

Ali Al-JanabiRichard Bruce Warren
Published in: The British journal of dermatology (2020)
Keyphrases
  • rheumatoid arthritis
  • high intensity
  • coronary artery disease
  • juvenile idiopathic arthritis
  • early onset
  • ulcerative colitis
  • hidradenitis suppurativa
  • drug induced
  • systemic lupus erythematosus